Global Age-related Macular Degeneration Market 2016-2020

Global Age-related Macular Degeneration Market 2016-2020

  • September 2016
  • 99 pages
  • Infiniti Research Limited
Report ID: 2183837
About AMD

AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.

Technavio’s analysts forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.

The market is divided into the following segments based on geography:
- Americas

Technavio's report, Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Bayer HealthCare
- F. Hoffmann-La Roche
- Novartis
- Regeneron Pharmaceuticals

Other prominent vendors
- Alcon
- Allergan
- Adverum Biotechnologies
- Bausch + Lomb
- Gilead Sciences
- Iconic Therapeutics
- Lpath
- Neurotech Pharmaceuticals
- Ohr Pharmaceutical
- Opthea
- Ophthotech
- PanOptica
- Pfizer
- Promedior
- Quark
- Resolvyx Pharmaceuticals
- RXi Pharmaceuticals
- Sagent Pharmaceuticals
- Santen Pharmaceuticals
- Sanwa Kagaku Kenkyusho

Market driver
- Increasing reimbursement benefits for AMD drugs
- For a full, detailed list, view our report

Market challenge
- Availability of alternative therapies
- For a full, detailed list, view our report

Market trend
- Novel treatment approaches for developing AMD drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=World Industry=Therapy ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=InfinitiResearchLimited Price=3000